A MODERN LOOK AT BREASTFEEDING IN NEONATAL HYPERBILIRUBINAEMIA

Медицинский совет. 2018;0(2):58-62 DOI 10.21518/2079-701X-2018-2-58-62

 

Journal Homepage

Journal Title: Медицинский совет

ISSN: 2079-701X (Print); 2658-5790 (Online)

Publisher: Remedium Group LLC

LCC Subject Category: Medicine

Country of publisher: Russian Federation

Language of fulltext: Russian

Full-text formats available: PDF

 

AUTHORS

S. I. Zhdanova (Kazan State Medical University)
L. F. Vakhitova (Kazan State Medical University)
O. I. Polyakova (Kazan State Medical University)

EDITORIAL INFORMATION

Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 6 weeks

 

Abstract | Full Text

The article describes the modern concepts of breastfeeding in neonatal jaundice with elevated indirect bilirubin levels: hemolytic disease of newborns, jaundice because of variations in the composition of the breast milk and exclusively-breastfed jaundice. According to the guidelines of the Russian Neonatal Society (RON), the Russian Association of Perinatal Medicine Specialists (RASPM) and the National Neonatology Guidelines, there are no contraindications to breastfeeding or receiving milk by children with hemolytic disease of newborns despite the presence of antibody titres during pregnancy. In the event of jaundice because of variations in the composition of the breast milk, breastfeeding may be dropped at 24th – 48th hour and in exceptional cases after the 5th day of life against the background of phototherapy used for its indications specified in the clinical guidelines. It is required to comply with WHO guidelines for BF management from the first hours of life to prevent jaundice caused by breastfeeding. It is a pathological loss of body weight which may be an indication for supplementary feeding with the mixture, but not the jaundice itself associated with breastfeeding.